Qiagen NV (WBO:QGE2)
€ 40.8 -0.54 (-1.31%) Market Cap: 9.01 Bil Enterprise Value: 9.48 Bil PE Ratio: 137.61 PB Ratio: 2.86 GF Score: 87/100

Qiagen NV at Cowen Health Care Conference (Virtual) Transcript

Mar 08, 2022 / 03:30PM GMT
Release Date Price: €39.71 (-5.50%)
Daniel Gregory Brennan
Cowen and Company, LLC, Research Division - Research Analyst

Good morning. Dan Brennan here. Day 2 of the Cowen Health Care Conference. I'm certainly thrilled to be here, having joined not too long ago and joined here on the virtual stage for this session with Thierry Bernard, the Chief Executive Officer of QIAGEN, who we hosted back in December and really enjoyed our meetings and I'm looking forward to this today.

So first off, Thierry, welcome.

Thierry Bernard
QIAGEN N.V. - CEO, MD & Member of Management Board

Thanks for having us.

Questions & Answers

Daniel Gregory Brennan
Cowen and Company, LLC, Research Division - Research Analyst

You got it. So I thought I'd have a series of maybe top-down questions to kick it off, and then we'll get into the 5 pillars, and then we'll talk about profitability and maybe end on some strategy things.

But maybe just from a high level to kick it off, Thierry, so your guidance this year calls for north of 10% core business

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot